The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
March 6th 2025
This February 2025 month in review covers key updates in endocrinology, including the end to the semaglutide shortage and new automated insulin delivery data.
February 21st 2025
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
The End of SGR: What Took So Long?
May 8th 2015For more than a decade, it has been an annual ritual to read headlines about a crisis brewing in Congress as it struggled to avert a looming Medicare disaster stemming from the imminent pay cut to Medicare physicians mandated by the "SGR". Like a broken record each time, spurred by warnings of physician groups of the dire consequences the slash in Medicare fees would have on medical practices and Medicare patients, Congress scrambled at the 12th hour to put off the mandated cuts for another year.
Diabetes Diagnosis Opens a Window of Opportunity for Weight Loss
May 5th 2015When patients are initially diagnosed with type 2 diabetes, clinicians usually recommend several lifestyle changes, including weight loss. Few studies have looked at weight changes in patients with type 2 diabetes around initial diagnosis, although it's clear that it is more difficult for patients with diabetes to lose weight than it is for others.
Chronic Itch: Gastrointestinal Peptides as Possible Contributors
May 5th 2015Chronic itch (itch last 6 weeks or longer) is a clinical challenge, and is associated with a number of dermatologic, systemic, neuropathic, and psychogenic causes. Transmission of the itch sensation is similar to that of pain, but distinct in several ways. Scientists have found itch-specific neuronal pathways that when activated, cause considerable discomfort for patients. Current available treatments, however, are still more trial-and-error than evidence-based.
Is Hair Restoration Worth the Risk of Potential Persistent Sexual Side Effects?
May 5th 2015Hair loss, whether it's partial or complete, is troubling to many people. By age 50, 35 to 50 percent of American men have significant hair loss, and hair thinning and loss increases with age. Many people associate hair loss with premature aging, making pharmaceuticals that arrest hair loss quite popular. However, they are not without certain side effects.
Liver Meeting Draws 11,000 to Vienna
An estimated 11,000 attendees from 105 countries are converging in Vienna, Austria for the 50th International Liver Congress, hosted by the European Association for the Study of the Liver (ILC/EASL). Some 200 journalists -- including a team from MD Magazine--are on hand to report the news. Eagerly awaited trials include those of two drugs that show promise for treating a common liver disease associated with obesity, known medically as non-alcoholic steatohepatitis (NASH) and its precursor non-alcoholic fatty liver disease (NAFLD).
Diet & Diabetes Prevention: Does the Specific Diet Matter?
April 22nd 2015The American Diabetes Association recommends eating fewer calories of better quality to prevent diabetes. Researchers looked at the available evidence from studies that examined a variety of diets and found that any healthy diet reduces the risk of diabetes by about 20%.
Denosumab: Can RANKL Inhibition Improve Insulin Resistance?
April 22nd 2015With more than 40 million Americans either diagnosed or at high risk for osteoporosis as they age, researchers are scrambling to find ideal preventive and curative agents. One target that strengthens bones is excessive osteoclast activity. A team of researchers recently found that one biologic that targets excessive osteoclast activity may positively influence another problem of later life: insulin sensitivity.
Glycated Albumin: The Next HgA1c?
April 15th 2015Albumin -- the most abundant protein in the human body -- has many roles. It transports hormones, fatty acids, and other compounds. It buffers serum pH, and maintains osmotic pressure. Now, it appears that albumin may be a tool that could be used in diabetes management.
FDA Panel Recommends Adding New Safety Warnings to Labels of 3 Diabetes Drugs
An advisory panel for the US Food and Drug Administration (FDA) held a hearing yesterday focusing on safety issues associated with two diabetes medications. Although the panel's recommendation did not include specific treatment changes, its decision highlighted the fact that more research is needed on cardiovascular risk associated with this class of diabetes medications.
Body Mass Index Shows Potential Link to Dementia
There has been considerable research regarding the unhealthy risks associated with being overweight later in life. A recent study has shown that being underweight can also have a negative effect on a person's life as they get older.
Chronic Kidney Disease: Sleep Problems Increases with Disease Progression
April 13th 2015Lack of sleep and chronic kidney disease (CKD) independently lead to hypertension, diabetes mellitus, lower quality of life, and shorter life expectancy. Severity of CKD and sleep disturbances may also worsen diabetes and hypertension synergistically.